HROW 42.44 (+6.9%)
US4158581094Drug ManufacturersDrug Manufacturers - Specialty & Generic

Harrow Health (HROW) Stock Highlights

42.44 | +6.9%
2024-11-21 03:03:08
Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.

Statistics

Range Today
39.85 42.52
Volume Today 585.8K
Range 1 Year
8.72 59.23
Volume 1 Year 128.32M
Range 3 Year
5.4 59.23
Volume 3 Year 280.2M
Range 10 Year
1.35 59.23
Volume 10 Year 603.01M

Highlights

Market Capitalization 1.86B (small)
Floating Shares 26.41M
Current Price 42.44
Price To Earnings -49.69
Price To Revenue 12.86
Price To Book 31.82
Earnings Per Share -1
Payout Ratio 0%

Performance

Latest +6.9%
1 Month -26.11%
3 Months +8.49%
6 Months +152.47%
1 Year +369.99%
3 Years +303.81%
5 Years +683.03%
10 Years +409.48%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.